It is time to make special efforts to provide public services and support to people who use drugs and communities that have been harmed by the so-called war on drugs. It is time to rethink the overall goals of drug policies to ensure that they are aligned with the Sustainable Development Agenda (GCDP)
Bibliography: International Policy Issues
Regulation – The Responsible Control of Drugs
The report identifies key questions that, in the Commission’s experience, have become particular stumbling blocks in the progress of the public dialogue on regulation (Global Commission on Drug Policy)
A model drug law for west Africa
Some governments are willing to consider reform and the WACD wants to further support this ongoing work with the Model Drug Law, which provides concrete templates that countries can adapt to reform their drug laws: legal provisions and how they relate to international legal obligations as well as useful commentary that explains different options and reasons for choosing the proposed legal solution ( Global Commission on Drug Policy)
Toward an Improved Multi-Criteria Drug Harm Assessment Process and Evidence-Based Drug Policies
The evidence-based multi-criteria drug harm scale (MCDHS) has been proposed as a way of grounding policy in the actual degree of harmfulness of drugs … This article reviews strengths and weaknesses of evidence provided with the use of MCDHS. Furthermore, the author argues that the shortcomings of MCDHS can be resolved by offering methodological improvements (Frontiers in Pharmacology)
World Drug Report 2018
Opioid crisis, prescription drug abuse expands; cocaine and opium hit record highs Index (UNODC)
General Report of Activities 2017 – Key achievements and governance: a year in review
The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking comprehensive information on the Centre and its work (EMCDDA)
European Drug Report 2018: Trends and Developments
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2018 European Drug Report package English (EMCDDA)
Balancing Treaty Stability and Change (PDF)
Inter se modification of the UN drug control conventions to facilitate cannabis regulation (GDPO)
Wastewater analysis and drugs — a European multi-city study (Perspectives on drugs)
The findings of the largest European project to date in the emerging science of wastewater analysis are taken up in this ‘Perspective on drugs’ (EMCDDA)
The Death Penalty for Drug Offences
Global Overview 2017 (HRI)
Environmental substance use prevention interventions in Europe
This report provides an overview of the range of environmental prevention interventions used in the substance use field and, based on a survey of prevention experts, paints a first picture of the extent to which environmental prevention measures are currently used in Europe as a starting point for future research (EMCDDA)
Programming document 2018–20
he EMCDDA Programming Document for the period 2018–20 covers the final year of implementation of the EMCDDA Strategy 2016–18 and coincides with the completion of the first Roadmap established under the new EMCDDA Strategy 2025
Costs and unintended consequences of drug control policies (PDF)
Report by the expert group on possible adverse effects and associated costs of drug control policies (Pompidou Group)
Counternarcotics – Afghanistan (PDF)
SIGAR’s quarterly report to US Congress
Measuring the ‘world drug problem’: ARQ Revision.
Beyond traditional indicators? (GDPO)
The world drug perception problem: countering prejudices about people who use drugs
The present report aims to analyze the most common perceptions and fears, contrast them with available evidence on drugs and the people who use them, and provides recommendations on changes that must be enacted to support reforms toward more effective drug policies (The Global Commission on Drug Policy)
Reducing the harm associated with drugs of abuse: the role of pharamacists (PDF)
This report represents the outcome of a literature search of a working group, their deliberations and insights (International Pharmaceutical Federation)
Drugs and the darknet: perspectives for enforcement, research and policy
A joint publication by the EMCDDA and Europol, presents the latest understanding of how darknet markets function, the threats they pose to health and security and how Europe can respond
Drug testing in schools
This paper evaluates the effectiveness of random testing in schools, based on studies conducted among students aged 13 to 19 years, in the United States. Although different with regard to study design and the type of testing offered, all of the studies show that testing has little or no effect on drug use (EMCDDA)
Exploring the Perils of Cross-national Comparisons of Drug Prevalence
Our preliminary efforts suggest that cross-national prevalence comparisons, policy analyses and, other projects such as estimating the global burden of disease could be improved by adjusting estimates from drug use surveys for differences in modality (RAND)
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 11
- Next Page »
